Chemotherapy News and Research

Latest Chemotherapy News and Research

UCSF physicians evlaute devices that could reduce hair loss in breast cancer patients undergoing chemotherapy

UCSF physicians evlaute devices that could reduce hair loss in breast cancer patients undergoing chemotherapy

14 Dec 2010
New osteoporosis drug appears to reduce bone loss in mice with oral cancer

New osteoporosis drug appears to reduce bone loss in mice with oral cancer

14 Dec 2010
CEL-SCI reports net income of $10.48M for fiscal 2010 vs. $40.9M loss for fiscal 2009

CEL-SCI reports net income of $10.48M for fiscal 2010 vs. $40.9M loss for fiscal 2009

13 Dec 2010
Inimex, SARomics Biostructures achieve scientific milestone in IMX942 IDR collaboration

Inimex, SARomics Biostructures achieve scientific milestone in IMX942 IDR collaboration

13 Dec 2010
GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be presented at 33rd CTRC-AACR

GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be presented at 33rd CTRC-AACR

13 Dec 2010
Syndax reports promising results from entinostat preclinical studies in breast cancer

Syndax reports promising results from entinostat preclinical studies in breast cancer

13 Dec 2010
Exemestane may provide post-surgery option for postmenopausal women with hormone-receptor positive breast cancer

Exemestane may provide post-surgery option for postmenopausal women with hormone-receptor positive breast cancer

13 Dec 2010
Do not delay breast cancer therapy during pregnancy

Do not delay breast cancer therapy during pregnancy

13 Dec 2010
Presence of circulating tumor cells in early-stage breast cancer doubles risk of relapse and death

Presence of circulating tumor cells in early-stage breast cancer doubles risk of relapse and death

13 Dec 2010
Scientists demonstrate triple-drug cocktail for triple negative breast cancer at AACR symposium

Scientists demonstrate triple-drug cocktail for triple negative breast cancer at AACR symposium

13 Dec 2010
Xeloda may reduce recurrence of faster growing breast cancers: Study

Xeloda may reduce recurrence of faster growing breast cancers: Study

13 Dec 2010
Cancer researchers identify six gene markers in early stage NSCLC

Cancer researchers identify six gene markers in early stage NSCLC

13 Dec 2010
Research programs embody the promise of anti-aging medicine.

Research programs embody the promise of anti-aging medicine.

13 Dec 2010
Boehringer Ingelheim reports positive results from afatinib phase IIb/III LUX-Lung 1 trial in advanced NSCLC

Boehringer Ingelheim reports positive results from afatinib phase IIb/III LUX-Lung 1 trial in advanced NSCLC

13 Dec 2010
Combination therapy improves tumor response in HER2-positive breast cancer patients

Combination therapy improves tumor response in HER2-positive breast cancer patients

13 Dec 2010
Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

13 Dec 2010
Novelos NOV-002 demonstrates positive results in Phase 2 neoadjuvant breast cancer trial

Novelos NOV-002 demonstrates positive results in Phase 2 neoadjuvant breast cancer trial

13 Dec 2010
CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

13 Dec 2010
Stem cell therapy can reduce risk of acute leukemia in affected individuals

Stem cell therapy can reduce risk of acute leukemia in affected individuals

13 Dec 2010
Researchers present Phase III study of neoadjuvant therapy with trastuzumab and lapatinib for early breast cancer

Researchers present Phase III study of neoadjuvant therapy with trastuzumab and lapatinib for early breast cancer

13 Dec 2010

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback